ReValve Solutions, Inc. Announces Successful First Human Use of the Transeptal Mitral Valve Replacement
ReValve Solutions, Inc., an innovator in the field of transcatheter structural heart replacement and repair, announced today it has successfully completed the first human use of its transcatheter, Palmetto System for mitral valve replacement. The patient was successfully treated who suffered from severe mitral valve regurgitation and heart failure. The transfemoral-transseptal procedure was performed at the Italian Hospital in Asuncion, Paraguay by Dr. Charles Davidson, (Medical Director, Bluhm Cardiovascular Institute) and Dr. Edris Aman, (Assistant Clinical Professor of Cardiovascular Medicine at the University of California, Davis Medicine Center specialized in Multimodality Imaging).
"The complexity of mitral valve pathology creates challenges for transcatheter therapies to treat effectively. The first in human experience with this innovative technology shows promise for patients with advanced mitral valve regurgitation,” said Charles Davidson, MD.
"The features of the Palmetto System allow for transseptal mitral valve replacement in native mitral regurgitation. This case highlights the potential for this technology, which is another step forward for transseptal mitral valve replacement,” said Edris Aman, MD.
“The case is a major step forward in Re-Imaging the treatment of structural heart disease. Our unique portfolio of technologies is based on our understanding of the evolution of disease and the need to provide for ongoing management of valvular heart disease. I am extremely proud of our team’s focus and dedication,” said Julie Logan Sands, CEO and Founder of ReValve Solutions
The Palmetto System is a complete mitral valve replacement. It is delivered via transfemoral-transeptal procedure. The system is design to avoid any disturbance to the left-ventricular outflow tract and if needed will allow for future valve replacement without compromising the orifice area. Preserving options for the physician and patient is an essential part of the solution to structure heart treatment.
About ReValve Solutions, Inc.
ReValve Solutions, Inc. (www.revalvesolutions.com ) is based in, Washington with the mission of delivering innovative solutions to structure heart disease through catheter-based procedures. Solutions that are tailored to the needs of the patient. For more information visit www.ReValveSolutions.com
Related Links http://www.revalvesolutions.com
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CT-NEL-HYDROGEN/OVAKO26.11.2021 20:47:07 CET | Press release
Nel ASA: Receives Purchase Order for 20MW Alkaline Electrolyser From Ovako
CA-METAGOOD26.11.2021 18:18:04 CET | Press release
'Afghan Girl' Sharbat Gula Safely Evacuated to Italy Via Efforts of Photographer Steve McCurry, Metagood/OnChainMonkey Crypto Community & Future Brilliance Charity
SHENZHEN-WOODY-VAPES26.11.2021 16:47:04 CET | Press release
ZOVOO Held Distributor Conference, Creating a Splash of Colour in Atomization Industry
QUANDOO26.11.2021 15:23:06 CET | Press release
Indeed and Quandoo Announce Partnership to Support the Restaurant Industry Hiring Crisis
TRUSTECH26.11.2021 10:36:11 CET | Press release
The Leading Event for Payment, Identification and Security Professionals, TRUSTECH will present all the Latest trends in the sector
VIFOR-PHARMA26.11.2021 07:02:06 CET | Press release
Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis
LIGHTCON26.11.2021 03:02:09 CET | Press release
LightCON Unveils Global Teaser Site for New Mobile Game 'Rise of Stars (ROS)'
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom